Self-referral for brief hospital admission to reduce self-harm
Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care
This study tests whether allowing people with self-harm tendencies and borderline personality disorder to admit themselves to the hospital for short stays can help them feel better and reduce their need for forced treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 7000 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Region Skane Academic / other |
| Locations | 4 sites (Lund, Skåne County and 3 other locations) |
| Trial ID | NCT06406972 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of a standardized treatment model called Brief Admission by self-referral (BA) on individuals with self-harm tendencies and borderline personality disorder. The approach promotes patient autonomy and aims to reduce the need for compulsory care. By comparing clinics that implement BA at different times, the study seeks to address challenges in evaluating the effectiveness of this model while minimizing cross-contamination between control and intervention groups. The research utilizes a register-based approach to gather data on patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 living in specific regions of Sweden with a history of self-harm or borderline personality disorder.
Not a fit: Patients who do not meet the inclusion criteria or have not experienced self-harm may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could empower patients and significantly reduce instances of self-harm and the need for compulsory psychiatric care.
How similar studies have performed: While randomized trials have shown limited differences in inpatient care, this study's register-based approach may provide new insights into the effectiveness of similar interventions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Living in the uptake area of Lund, Linköping, Helsingborg or Norrköping * Age 18-65 years at the time of inclusion * Admitted to hospital either diagnosed with ICD-10 diagnosis BPD F60.3, or admitted at least twice with Intentional self-harm X60-83 in combination with one of more of the following diagnoses ADHD (F90.0-F90.X), Bipolar disorder type 2, (F31.8W, F318A-F, F31.0, F31.8-9, F31.8W) or Autism, Atypical autism, Aspergers syndrome (F84.0, F84.1, F84.5) or Mild intellectual disability (F70.0-F70.9). Exclusion Criteria: * not fulfilling inclusion criteria
Where this trial is running
Lund, Skåne County and 3 other locations
- Division of Psychiatry, Region Skåne — Lund, Skåne County, Sweden (Recruiting)
- Region Östergötland — Linköping, Sweden (Recruiting)
- Statistiska centralbyrån — Solna, Sweden (Recruiting)
- Socialstyrelsen — Stockholm, Sweden (Recruiting)
Study contacts
- Principal investigator: Sofie Sofie, PhD — Lund University
- Study coordinator: Sofie Sofie, PhD
- Email: sofie.westling@med.lu.se
- Phone: +46735626099
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.